[18F]fluorodeoxyglucose and [18F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre study
Jean‐Charles Nault, Marouane Boubaya, Myriam Wartski, Anthony Dohan, Stanislas Pol, Gabriel Pop, Michaël Soussan, Olivier Sutter, Charlotte Costentin, Julie Roux, Christian Sengel, Marie Lequoy, Françoise. Montravers, Y. Menu, Georges‐Philippe Pageaux, D. Mariano Goulart, Boris Guiu, Alain Luciani, Pierre Nahon, Marco Dioguardi Burgio, Mathilde Wagner, Philippe Maksud, Sebastien Mulé, Manon Allaire, Sabrina Sidali, Audrey Coilly, Florent L. Besson, M. Lewin, Hélène Regnault, Clémence Hollande, Giuliana Amaddeo, Maxime Ronot, Nathalie Ganne‐Carrié, Emmanuel Itti, Coralie Bloch‐Queyrat, Vincent Lévy, Rachida Lebtahi, Julia Chalaye, Mohamed Bouattour
Topics & Concepts
Hepatocellular carcinomaMedicineFluorodeoxyglucoseNuclear medicineRadiologyPET-CTPositron emission tomographyInternal medicineHepatocellular Carcinoma Treatment and PrognosisMedical Imaging Techniques and ApplicationsCholangiocarcinoma and Gallbladder Cancer Studies